A Narrative Review of the Relationship Between Coronary Heart Disease and Anxiety

Authors Information
Article Notes and Dates
To Cite : Dahale A B, C Menon J, T. S. J. A Narrative Review of the Relationship Between Coronary Heart Disease and Anxiety, Iran J Psychiatry Behav Sci. 2017 ;11(3):e7722. doi: 10.5812/ijpbs.7722.
Copyright: Copyright © 2017, Iranian Journal of Psychiatry and Behavioral Sciences. .
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Conclusion
Footnotes
References
  • 1. World Health Organization. . The World health report: 2004: Changing history. 2004;
  • 2. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007; 370(9592): 1089-100[DOI][PubMed]
  • 3. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004; 66(6): 814-22[DOI][PubMed]
  • 4. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003; 65(2): 201-10[DOI][PubMed]
  • 5. Lane D, Carroll D, Lip GY. Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? J Am Coll Cardiol. 2003; 42(10): 1808-10[DOI][PubMed]
  • 6. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006; 21(1): 30-8[DOI][PubMed]
  • 7. Hanssen TA, Nordrehaug JE, Eide GE, Bjelland I, Rokne B. Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population. Eur J Cardiovasc Prev Rehabil. 2009; 16(6): 651-9[DOI][PubMed]
  • 8. Huffman JC, Stern TA. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med. 2003; 25(4): 427-37[DOI][PubMed]
  • 9. Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, et al. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med. 2007; 120(6): 525-30[DOI][PubMed]
  • 10. Gomez-Caminero A, Blumentals WA, Russo LJ, Brown RR, Castilla-Puentes R. Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosom Med. 2005; 67(5): 688-91[DOI][PubMed]
  • 11. Walters K, Rait G, Petersen I, Williams R, Nazareth I. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J. 2008; 29(24): 2981-8[DOI][PubMed]
  • 12. Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007; 64(10): 1153-60[DOI][PubMed]
  • 13. Tully PJ, Wittert GA, Turnbull DA, Beltrame JF, Horowitz JD, Cosh S, et al. Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol. Syst Rev. 2015; 4: 33[DOI][PubMed]
  • 14. Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Disord. 2005; 88(1): 87-91[DOI][PubMed]
  • 15. Kubzansky LD, Koenen KC, Spiro A3, Vokonas PS, Sparrow D. Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the Normative Aging Study. Arch Gen Psychiatry. 2007; 64(1): 109-16[DOI][PubMed]
  • 16. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 2010; 56(1): 31-7[DOI][PubMed]
  • 17. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005; 111(4): 480-7[DOI][PubMed]
  • 18. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010; 56(1): 38-46[DOI][PubMed]
  • 19. Overbaugh KJ. Acute coronary syndrome. Am J Nurs. 2009; 109(5): 42-52[DOI][PubMed]
  • 20. Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL. Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. J Psychosom Res. 2008; 65(6): 557-63[DOI][PubMed]
  • 21. Abu Ruz ME, Lennie TA, Moser DK. Effects of beta-blockers and anxiety on complication rates after acute myocardial infarction. Am J Crit Care. 2011; 20(1): 67-73[DOI][PubMed]
  • 22. Wang G, Cui J, Wang Y, Deng B, Liang X, Bai J, et al. Anxiety and adverse coronary artery disease outcomes in Chinese patients. Psychosom Med. 2013; 75(6): 530-6[DOI][PubMed]
  • 23. Moser DK, Riegel B, McKinley S, Doering LV, An K, Sheahan S. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med. 2007; 69(1): 10-6[DOI][PubMed]
  • 24. Benninghoven D, Kaduk A, Wiegand U, Specht T, Kunzendorf S, Jantschek G. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother Psychosom. 2006; 75(1): 56-61[DOI][PubMed]
  • 25. Park JH, Tahk SJ, Bae SH. Depression and anxiety as predictors of recurrent cardiac events 12 months after percutaneous coronary interventions. J Cardiovasc Nurs. 2015; 30(4): 351-9[DOI][PubMed]
  • 26. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom. 2004; 73(6): 344-52[DOI][PubMed]
  • 27. Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008; 65(1): 62-71[DOI][PubMed]
  • 28. Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study. Arch Gen Psychiatry. 2010; 67(7): 750-8[DOI][PubMed]
  • 29. Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB Jr, Sketch MJ. Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med. 2006; 68(5): 651-6[DOI][PubMed]
  • 30. Watkins LL, Blumenthal JA, Babyak MA, Davidson JR, McCants CJ, O'Connor C, et al. Phobic anxiety and increased risk of mortality in coronary heart disease. Psychosom Med. 2010; 72(7): 664-71[DOI][PubMed]
  • 31. Moser DK, McKinley S, Riegel B, Doering LV, Meischke H, Pelter M, et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosom Med. 2011; 73(9): 803-9[DOI][PubMed]
  • 32. Doering LV, Moser DK, Riegel B, McKinley S, Davidson P, Baker H, et al. Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease. Int J Cardiol. 2010; 145(2): 188-92[DOI][PubMed]
  • 33. Watkins LL, Koch GG, Sherwood A, Blumenthal JA, Davidson JR, O'Connor C, et al. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc. 2013; 2(2)[DOI][PubMed]
  • 34. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med. 2000; 62(2): 212-9[DOI][PubMed]
  • 35. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med. 2001; 63(2): 221-30[DOI][PubMed]
  • 36. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? QJM. 2000; 93(11): 739-44[DOI][PubMed]
  • 37. Pelletier R, Bacon SL, Arsenault A, Dupuis J, Laurin C, Blais L, et al. Relative associations between depression and anxiety on adverse cardiovascular events: does a history of coronary artery disease matter? A prospective observational study. BMJ Open. 2015; 5(12)[DOI][PubMed]
  • 38. Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. Am Heart J. 2015; 170(6): 1105-15[DOI][PubMed]
  • 39. Parker GB, Owen CA, Brotchie HL, Hyett MP. The impact of differing anxiety disorders on outcome following an acute coronary syndrome: time to start worrying? Depress Anxiety. 2010; 27(3): 302-9[DOI][PubMed]
  • 40. Herrmann C, Brand-Driehorst S, Buss U, Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 2000; 48(4-5): 455-62[DOI][PubMed]
  • 41. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007; 69(4): 323-31[DOI][PubMed]
  • 42. Fleet R, Lesperance F, Arsenault A, Gregoire J, Lavoie K, Laurin C, et al. Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol. 2005; 96(8): 1064-8[DOI][PubMed]
  • 43. Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis. Front Psychiatry. 2014; 5: 80[DOI][PubMed]
  • 44. Diveky T, Prasko J, Latalova K, Grambal A, Kamaradova D, Silhan P, et al. Heart rate variability spectral analysis in patients with panic disorder compared with healthy controls. Neuro Endocrinol Lett. 2012; 33(2): 156-66[PubMed]
  • 45. Lavoie KL, Fleet RP, Laurin C, Arsenault A, Miller SB, Bacon SL. Heart rate variability in coronary artery disease patients with and without panic disorder. Psychiatry Res. 2004; 128(3): 289-99[DOI][PubMed]
  • 46. Esler M, Alvarenga M, Lambert G, Kaye D, Hastings J, Jennings G, et al. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann N Y Acad Sci. 2004; 1018: 505-14[DOI][PubMed]
  • 47. Paterniti S, Zureik M, Ducimetiere P, Touboul PJ, Feve JM, Alperovitch A. Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2001; 21(1): 136-41[PubMed]
  • 48. Seldenrijk A, Vogelzangs N, van Hout HP, van Marwijk HW, Diamant M, Penninx BW. Depressive and anxiety disorders and risk of subclinical atherosclerosis Findings from the Netherlands Study of Depression and Anxiety (NESDA). J Psychosom Res. 2010; 69(2): 203-10[DOI][PubMed]
  • 49. Seldenrijk A, van Hout HP, van Marwijk HW, de Groot E, Gort J, Rustemeijer C, et al. Depression, anxiety, and arterial stiffness. Biol Psychiatry. 2011; 69(8): 795-803[DOI][PubMed]
  • 50. Hernandez R, Allen NB, Liu K, Stamler J, Reid KJ, Zee PC, et al. Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis: results from the Chicago Healthy Aging Study (CHAS). Prev Med. 2014; 61: 54-60[DOI][PubMed]
  • 51. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006; 185(2): 320-6[DOI][PubMed]
  • 52. Stillman AN, Moser DJ, Fiedorowicz J, Robinson HM, Haynes WG. Association of anxiety with resistance vessel dysfunction in human atherosclerosis. Psychosom Med. 2013; 75(6): 537-44[DOI][PubMed]
  • 53. De Kloet ER. Hormones and the stressed brain. Ann N Y Acad Sci. 2004; 1018: 1-15[DOI][PubMed]
  • 54. Gerra G, Zaimovic A, Zambelli U, Timpano M, Reali N, Bernasconi S, et al. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology. 2000; 42(2): 82-92[PubMed]
  • 55. Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl. 2000; (406): 24-9[DOI][PubMed]
  • 56. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005; 178(2): 339-44[DOI][PubMed]
  • 57. Hamer M, Molloy GJ, Stamatakis E. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J Am Coll Cardiol. 2008; 52(25): 2156-62[DOI][PubMed]
  • 58. Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev. 2003; (2)[DOI][PubMed]
  • 59. Arbanas G, Arbanas D, Dujam K. Adverse effects of benzodiazepines in psychiatric outpatients. Psychiatr Danub. 2009; 21(1): 103-7[PubMed]
  • 60. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JJ, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002; 288(6): 701-9[PubMed]
  • 61. Strik JJ, Honig A, Lousberg R, Lousberg AH, Cheriex EC, Tuynman-Qua HG, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med. 2000; 62(6): 783-9[PubMed]
  • 62. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005; 62(7): 792-8[DOI][PubMed]
  • 63. Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007; 297(4): 367-79[DOI][PubMed]
  • 64. Hansen BH, Hanash JA, Rasmussen A, Hansen JF, Andersen NL, Nielsen OW, et al. Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD). J Psychosom Res. 2012; 72(1): 11-6[DOI][PubMed]
  • 65. Kim JM, Stewart R, Bae KY, Kang HJ, Kim SW, Shin IS, et al. Effects of depression co-morbidity and treatment on quality of life in patients with acute coronary syndrome: the Korean depression in ACS (K-DEPACS) and the escitalopram for depression in ACS (EsDEPACS) study. Psychol Med. 2015; 45(8): 1641-52[DOI][PubMed]
  • 66. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. 2008; 65(7): 795-803[DOI][PubMed]
  • 67. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000; 108(1): 2-8[DOI][PubMed]
  • 68. Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension. 2009; 53(4): 631-8[DOI][PubMed]
  • 69. Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med. 2007; 69(7): 606-13[DOI][PubMed]
  • 70. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AM, Crijns HJ, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry. 2007; 190: 460-6[DOI][PubMed]
  • 71. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003; 289(23): 3106-16[DOI][PubMed]
  • 72. Whalley B, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease: cochrane systematic review and meta-analysis. Int J Behav Med. 2014; 21(1): 109-21[DOI][PubMed]
  • 73. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007; 28(24): 2972-84[DOI][PubMed]
  • 74. Mavrides N, Nemeroff C. Treatment of depression in cardiovascular disease. Depress Anxiety. 2013; 30(4): 328-41[DOI][PubMed]
  • 75. Blumenthal JA, Sherwood A, Gullette EC, Babyak M, Waugh R, Georgiades A, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med. 2000; 160(13): 1947-58[DOI][PubMed]
  • 76. McGrady A, McGinnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009; 29(6): 358-64[DOI][PubMed]
  • 77. Phillips AC, Batty GD, Gale CR, Deary IJ, Osborn D, MacIntyre K, et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study. Psychosom Med. 2009; 71(4): 395-403[DOI][PubMed]
  • 78. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull. 2005; 131(2): 260-300[DOI][PubMed]
  • 79. Denollet J. Depression, anxiety, and trait negative affect as predictors of cardiac events: ten years after. Psychosom Med. 2008; 70(8): 949-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Psychiatry and Behavioral Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check